Sunshine Heart pays $5m for Baxter ’ s Aquadex
Sunshine Heart (NSDQ:SSH) said today that it agreed to pay about $5 million for the Aquadex fluid filtration device Baxter (NYSE:BAX) acquired when it bought Gambro in 2013.
The Aquadex device is designed to filter salt and water in patients with renal failure experiencing fluid overload. The deal calls for Eden Prairie, Minn.-based Sunshine Heart to pay $4 million in cash and another 1 million in SSH shares, worth about $950,000 at their August 5 closing price of 95¢ apiece.
Baxter paid $3.9 billion to acquire Swedish dialysis giant Gambro and the Aquadex device in September 2013.
Sunshine Heart’s flagship...
Source: Mass Device - August 8, 2016 Category: Medical Equipment Authors: Brad Perriello Tags: Dialysis Mergers & Acquisitions Wall Street Beat Baxter International Sunshine Heart Inc. Source Type: news
Africa: Chronic Diseases Need State Action
[Daily News] Medical practitioners and researchers in the country want the government to start thinking about providing free treatment for chronic diseases like renal failure, hypertension and diabetes for the benefit of people on antiretroviral drugs. (Source: AllAfrica News: HIV-Aids and STDs)
Source: AllAfrica News: HIV-Aids and STDs - July 4, 2016 Category: Infectious Diseases Source Type: news
Genetics Home Reference: action myoclonus-renal failure syndrome
https://ghr.nlm.nih.gov/condition/action-myoclonus-renal-failure-syndrome (Source: NLM General Announcements)
Source: NLM General Announcements - June 21, 2016 Category: Databases & Libraries Source Type: news
Gout Drug Fends Off Renal Failure (CME/CE)
(MedPage Today) -- Risks were lowest for dosages of 300 mg/day or higher (Source: MedPage Today Geriatrics)
Source: MedPage Today Geriatrics - June 15, 2016 Category: Geriatrics Source Type: news
RAS Inhibitors and Kidney, CV Outcomes in Patients With CKDRAS Inhibitors and Kidney, CV Outcomes in Patients With CKD
How is the risk for renal failure and cardiovascular events impacted in patients with chronic kidney disease treated with RAS inhibitors? American Journal of Kidney Diseases (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - June 15, 2016 Category: Consumer Health News Tags: Nephrology Journal Article Source Type: news
Lupus patients 'at higher risk of developing other health conditions'
People with lupus are at a greater risk of developing other health conditions than members of the general population.This is according to a new study conducted by the University of Nottingham and the Arthritis Research UK Primary Care Centre at Keele University, which examined the frequency of comorbidities associated with systemic lupus erythematosus in the UK between 1999 and 2012.A broad UK study Published in the medical journal Arthritis Care & Research, the study drew upon data from the UK Clinical Practice Research Datalink, identifying cases of lupus and matching each one by age, gender and practice to four heal...
Source: Arthritis Research UK - May 26, 2016 Category: Rheumatology Source Type: news
MassDevice.com +5 | The top 5 medtech stories for May 23, 2016
Say hello to MassDevice +5, a bite-sized view of the top five medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 5 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.
Get this in your inbox everyday by subscribing to our newsletters.
5. Baxter touts data on Theranova Dialyser efficacy, toxin clearance
Baxter today presented data from 24 different abstracts on treatments for end-stage kidney disease, touting 8 that covered its Theranova dialyser, indicated for ...
Source: Mass Device - May 23, 2016 Category: Medical Equipment Authors: MassDevice Tags: News Well Plus 5 Source Type: news
Baxter touts data on Theranova Dialyser efficacy, toxin clearance
Baxter (NYSE:BAX) today presented data from 24 different abstracts on treatments for end-stage kidney disease, touting 8 that covered its Theranova dialyser, indicated for treating chronic and acute renal failure.
The study data was presented at the European Renal Association and European Dialysis and Transplant Association’s 53rd Congress this week.
”Regardless of where dialysis therapy is performed – in a hospital, in a centre or at home – Baxter is actively researching unique solutions, introducing innovative technologies and elevating scientific exchange to advance renal care. Baxter presented data at...
Source: Mass Device - May 23, 2016 Category: Medical Equipment Authors: Fink Densford Tags: Clinical Trials Dialysis Baxter International Source Type: news
Methadone for fun sake… kidneys are at stake!!! - Chaudhari S, W.hedkar K, Popis-Matejak B, Baumstein D.
Acute renal failure from rhabdomyolysis is a well-established clinical entity; however, rhabdomyolysis exclusively caused by the ingestion of methadone requiring hemodialysis is very uncommon. With a similar mechanism to opiates, methadone can cause rhabdo... (Source: SafetyLit)
Source: SafetyLit - April 13, 2016 Category: Global & Universal Tags: Alcohol and Other Drugs Source Type: news
Fatal toxic myocarditis induced by paraphenylene diamine: a case report - Jedidi M, Hadj MB, Masmoudi T, Adelkarim SB, Mlayeh S, Dhiab MB, Souguir MK.
Para phenyl diamine (PPD) is an aromatic amine derivative of Aniline that is widely used as a cosmetic product, particularly in hair dye preparations. PPD acute poisoning leads to respiratory distress, rhabdomyolysis, muscle necrosis and renal failure. Car... (Source: SafetyLit)
Source: SafetyLit - April 13, 2016 Category: Global & Universal Tags: Home and Consumer Product Safety Source Type: news
Tourniquets in Field Management of Active Bleeding
This study was groundbreaking. First, it was a prospective study; second, it found a complication rate of 1.7% limited to nerve palsies. These updated findings on complications of the device have helped to allay prior fears of morbidity that deterred tourniquet use.
Following suit, the civilian community conducted its own research. Yielding low complication rates and high potential benefits, this research bolstered the recommendation for aggressive early tourniquet use.7 Mirroring the wave of change in military protocols, by 2012 some large metropolitan areas began equipping ambulances with commercial tourniquets and ...
Source: JEMS Patient Care - April 6, 2016 Category: Emergency Medicine Authors: Elisabeth White, MD Tags: Major Incidents Trauma Source Type: news
Could Modern Medicine Be Harming Older Patients?
Medically speaking, if you are above the age of 65, you are considered an "older adult." On conducting rounds on the cardiology unit, I find it rare to see anyone less than 65 years of age. If someone below 50 years old gets admitted, they are almost considered "pediatric" from a cardiovascular perspective. Such observations reflect the realities of modern medicine. Patients are older, more frail, have multiple co-morbidities, and have complex social issues. During the next 25 years, the population age greater than 85 years will be more than double -- from 6.3 million in 2015 to 14.1 million by 2040. Yet for my older patie...
Source: Healthy Living - The Huffington Post - March 28, 2016 Category: Consumer Health News Source Type: news
Febuxostat for Gout With Renal Failure Appears Feasible (CME/CE)
(MedPage Today) -- Target urate levels reached with no effect on kidney function (Source: MedPage Today Geriatrics)
Source: MedPage Today Geriatrics - February 27, 2016 Category: Geriatrics Source Type: news
